Clinical Trials Logo

Clinical Trial Summary

The main objectives were: 1) To determine the efficacy of both cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia, and 2) To compare the side-effects between the treatment for xerostomia with cevimeline and with pilocarpine.


Clinical Trial Description

Pilocarpine is a cholinergic agonist with predominant muscarinic action.As such, it acts at muscarinic-cholinergic receptors found throughout the body and promotes fluid secretion. Due to this, one of the main side-effects of pilocarpine is an increased amount of sweating. Thus, not only are the salivary glands stimulated, but all of the body's exocrine glands' production is heightened. On the other hand, cevimeline is a drug with a high affinity for specific muscarinic receptors (M3) located on lachrymal and salivary gland epithelium. At least in theory, cevimeline will produce less side effects compared with pilocarpine because of the higher affinity for the muscarinic receptors located in the salivary glands. A limited number of human clinical trials in the efficacy of cevimeline and pilocarpine to increase the production of saliva and the side effects have been performed with no conclusive results.

The main purposes of this study were to determine the efficacy of cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia, and to compare the side-effects between these two medications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01690052
Study type Interventional
Source University of Kentucky
Contact
Status Completed
Phase N/A
Start date January 2009
Completion date July 2010

See also
  Status Clinical Trial Phase
Completed NCT04914208 - Effect of Wearing Face Masks on Salivary Parameters and Halitosis N/A
Completed NCT00601211 - Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions N/A
Completed NCT00601874 - Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions N/A
Completed NCT04152642 - A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse N/A
Completed NCT03215251 - Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients in ICUs N/A
Completed NCT04632004 - Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health N/A
Completed NCT05640362 - Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial N/A
Not yet recruiting NCT06412627 - The Effect of Intervention About Dry Mouth and Thirst in Patients With Endotracheal Tube N/A
Completed NCT04986501 - Clinical Evaluation of MucoPEG™ for Xerostomia N/A
Completed NCT04189081 - Improvement of Dry Mouth Sufferers After Using an Experimental Dry Mouth Rinse Compared to a Water Control N/A
Completed NCT05871580 - Effect to the Photobiomodulation in the Burning Mouth Syndrome N/A
Completed NCT06258603 - Oral Care of Intubated Intensive Care Patient N/A
Completed NCT01737307 - Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy Phase 2
Completed NCT01647737 - Green Tea Lozenges for the Management of Dry Mouth Phase 1/Phase 2
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Completed NCT03035825 - Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients N/A
Recruiting NCT05964959 - A Mouth Education Program for Dry Mouth N/A
Withdrawn NCT02123147 - Examining the Immunological Process of Autoimmune Patients N/A
Completed NCT01885065 - Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients N/A
Completed NCT03281486 - "Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth N/A